Abstract OBJECTIVE: To study the difference in clinico-pathological features between IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis (HSPN) in children. METHODS: The medical data of 103 children with HSPN and 61 children with IgAN were retrospectively studied. RESULTS: There were no significant differences in age, sex and disease course between the HSPN and IgAN groups (P>0.05). Clinical classification demonstrated that more severe conditions were found in the IgAN group than in the HSPN group and gross hematuria was more common in the IgAN group (P<0.05). Serum creatinine and cholesterol levels were higher in the IgAN group than in the HSPN group (P<0.05). Fibrinogen-related antigen deposition was more common in the HSPN group, while complement 3(C3) deposition was more common in the IgAN group. Interstitial fibrosis, tubular casts and tubular inflammatory infiltration were also more common in the IgAN group (P<0.05). CONCLUSIONS: Significant clinico-pathological differences can be found between HSPN and IgAN in children, and these differences do not support a one disease entity hypothesis.
GUO Hong-Xiang,ZHANG Jian-Jiang,SHI Pei-Pei et al. A clinico-pathological comparison between Henoch-Schonlein purpura nephritis and IgA nephropathy in children[J]. 中国当代儿科杂志, 2012, 14(07): 506-509.
GUO Hong-Xiang,ZHANG Jian-Jiang,SHI Pei-Pei et al. A clinico-pathological comparison between Henoch-Schonlein purpura nephritis and IgA nephropathy in children[J]. CJCP, 2012, 14(07): 506-509.
［1］Liu H, Peng Y, Liu F, Xiao W, Zhang Y, Li W. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy［J］.Inflamm Res, 2011, 60(9): 869-878.
［2］Meadow SR, Scott DC. Berger disease: Henoch-Schonlein nephritis without the rash［J］. J Pediatr, 1985, 106(1): 27-32.
［7］Stanqou M, Ekonomidou D, Giamalis P, Liakou H, Tsiantoulas A, Pantzaki A, et al. Steroids and azathioprine in the treatment of IgA nephropathy［J］. Clin Exp Nephrol, 2011, 15(3): 373-380.
［11］Floege J, Floege A, Eitner F. IgA-Nephropathie［J］. Nephrologe, 2011, 6(4): 212-219.
［12］Xia Y, Mao J, Chen Y, Wang D, Cao L, Yao S, et al. Clinical outcomes in children with Henoch-Sch-nlein purpura nephritis grade IIIa or IIIb［J］. PediatrNephrol, 2011, 26(7): 1083-1088.
［13］Wakaki H, Ishikura K, Hataya H, Hamasaki Y, Sakai T, Yata N, et al. Henoch-Sch-nlein purpura nephritis with nephrotic state in children: predictors of poor outcomes［J］. Pediatr Nephrol, 2011, 26(6): 921-925.
［14］Kawasaki Y, Suyama K, Hashimoto K, Hosoya M. Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis［J］. Clin Rheumatol, 2011, 30(4): 529-535.
